TG
OMED

TCW Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

TCW Group’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,034
Closed -$439K – 782
2014
Q1 		$439K Sell
13,034
-52,328
-80% -$1.76M ﹤0.01% 729
2013
Q4 		$1.93M Sell
65,362
-59,625
-48% -$1.09M 0.01% 673
2013
Q3 		$1.91M Buy
+124,987
New +$2.32M 0.01% 667

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCW Group's OMED Position: Q2 2014 in Review

TCW Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2014, closing a stake of 13,034 shares — an estimated $439K sold.

TCW Group first reported a position in OMED in Q3 2013 and held it in 3 quarters. The position peaked at $1.93M in Q4 2013. 63 funds tracked by Wall St. Rank hold OMED as of Q2 2014.

  • TCW Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • TCW Group sold 13,034 OncoMed Pharmaceuticals, Inc. shares in Q2 2014, an estimated $439K.
  • TCW Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 3 quarters.
  • TCW Group's OncoMed Pharmaceuticals, Inc. position peaked at $1.93M in Q4 2013.
  • 63 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2014.

Based on TCW Group's 13F filing for Q2 2014, filed 14 Aug 2014.